How much funding has LimFlow raised?

LimFlow has raised $73.5M in total funding, most recently a Series D round.

Who are LimFlow's investors?

LimFlow's investors include Sofinnova Partners, Inari Medical, Longitude Capital, Soleus Capital, Bpifrance.

Where is LimFlow headquartered?

LimFlow is headquartered in Irvine, California, United States.

What industry is LimFlow in?

LimFlow operates in Healthcare.

LimFlow

Acquired

Purpose-Built for Possibility

Irvine, United States · Founded 2012 · $73.5M raised

Healthcare

Headquarters: Irvine, California
Employees: 11–50
Founded: 2012
Business Model: B2B

Website: limflow.com
Total Funding: $73.5M
Last Round: $40.0M Series DApr 2022
Rounds: 3

About

LimFlow SA, now part of Stryker via Inari Medical, is a medical device company that developed the LimFlow System — the only purpose-built solution for Transcatheter Arterialization of Deep Veins (TADV). The technology restores blood flow to the ischemic foot using a minimally invasive percutaneous procedure, offering a last-resort treatment option for end-stage Chronic Limb-Threatening Ischemia (CLTI) patients facing amputation. Its clinical PROMISE III trial demonstrated 87% limb salvage and 80% wound healing at six months, making it a breakthrough for 'no-option' vascular patients.

Summary

LimFlow is a Healthcare company based in Irvine, United States, founded in 2012. It has raised $73.5M in total across 3 rounds, most recently a $40.0M Series D round in Apr 2022. Investors include Sofinnova Partners, Inari Medical and Longitude Capital.